Marc V. D. V.
- Country
- The Netherlands
- Department
- Internal Medicine/Infectious disease
Research Overview
- Phase 3 Randomized Open‑Label Study of Switching to Lenacapavir Combined with Teropavimab and Zinlirvimab in Virologically Suppressed Adults with HIV‑1
- Evaluation of Efficacy, Safety, and Tolerability of Switching from Bictegravir/Emtricitabine/Tenofovir Alafenamide to Dolutegravir/Lamivudine in Virologically Suppressed HIV Patients Aged 50+
- Perioperative Administration of Tranexamic Acid to Reduce Hemorrhage in Morbid Obesity Patients Undergoing Gastric Bypass: A Randomized Controlled Trial
Data & Insights
Has run more than one trial at 24 of 88 partner sites.
Specializations
HIV Treatment Optimization
This investigator specializes in advancing treatment strategies for HIV-positive patients, with particular emphasis on managing virologic suppression in various patient populations.
- Antiretroviral therapy regimens
- Treatment switching strategies
- Long-term viral suppression
A key focus lies in evaluating novel therapeutic approaches for maintaining viral control in experienced patients.
Innovative HIV Therapeutics
The investigator explores next-generation HIV treatment options, including weekly oral regimens and novel drug combinations for improving patient care.
- Novel drug combinations
- Simplified treatment schedules
- Alternative therapeutic approaches
Research focuses on comparing emerging treatments with established standards of care.
Treatment-Naïve HIV Management
Expertise extends to studying initial therapy options for previously untreated HIV-positive individuals, evaluating antiretroviral efficacy and safety profiles.
- First-line treatment strategies
- Comparative effectiveness studies
- Safety and tolerability assessment
The work encompasses evaluation of antiretroviral activity in treatment-naïve populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.